Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210
Law, 2001, Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma, Cancer, 92, 160, 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X
Barnholtz-Sloan, 2004, Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, J Clin Oncol, 22, 2865, 10.1200/JCO.2004.12.149
Chen, 2007, Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain, Cancer, 109, 1668, 10.1002/cncr.22565
Stuschke, 1999, Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects, J Clin Oncol, 17, 2700, 10.1200/JCO.1999.17.9.2700
Borgelt, 1980, The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group, Int J Radiat Oncol Biol Phys, 6, 1, 10.1016/0360-3016(80)90195-9
Borgelt, 1981, Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group, Int J Radiat Oncol Biol Phys, 7, 1633, 10.1016/0360-3016(81)90184-X
Gaspar, 1997, Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, 37, 745, 10.1016/S0360-3016(96)00619-0
Priestman, 1996, Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases, Clin Oncol (R Coll Radiol), 8, 308, 10.1016/S0936-6555(05)80717-4
Sperduto, 2010, Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients, Int J Radiat Oncol Biol Phys, 77, 655, 10.1016/j.ijrobp.2009.08.025
Brown, 2015, NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases, J Clin Oncol, 33, LBA4, 10.1200/jco.2015.33.18_suppl.lba4
Lee, 2014, Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases, J Natl Cancer Inst, 106, dju151, 10.1093/jnci/dju151
Mehta, 2009, Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial, Int J Radiat Oncol Biol Phys, 73, 1069, 10.1016/j.ijrobp.2008.05.068
Chao, 1954, Roentgen-ray therapy of cerebral metastases, Cancer, 7, 682, 10.1002/1097-0142(195407)7:4<682::AID-CNCR2820070409>3.0.CO;2-S
Order, 1968, Improvement in quality of survival following whole-brain irradiation for brain metastasis, Radiology, 91, 149, 10.1148/91.1.149
Tsao, 2012, Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003869.pub3
Horton, 1971, The management of metastases to the brain by irradiation and corticosteroids, Am J Roentgenol Radium Ther Nucl Med, 111, 334, 10.2214/ajr.111.2.334
Rades, 2007, Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients, Cancer, 110, 1077, 10.1002/cncr.22877
Tsao, 2012, International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control, Clin Oncol (R Coll Radiol), 24, e81, 10.1016/j.clon.2012.03.008
Andrews, 2004, Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial, Lancet, 363, 1665, 10.1016/S0140-6736(04)16250-8
Langer, 2005, Current management of brain metastases, with a focus on systemic options, J Clin Oncol, 23, 6207, 10.1200/JCO.2005.03.145
Mehta, 2003, Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases, J Clin Oncol, 21, 2529, 10.1200/JCO.2003.12.122
Soffietti, 2005, Radiotherapy and chemotherapy of brain metastases, J Neurooncol, 75, 31, 10.1007/s11060-004-8096-3
Kaal, 2005, Therapeutic management of brain metastasis, Lancet Neurol, 4, 289, 10.1016/S1474-4422(05)70072-7
Khuntia, 2006, Whole-brain radiotherapy in the management of brain metastasis, J Clin Oncol, 24, 1295, 10.1200/JCO.2005.04.6185
Sneed, 1996, Radiotherapy for cerebral metastases, Neurosurg Clin N Am, 7, 505, 10.1016/S1042-3680(18)30376-0
Mehta, 2011, The dandelion effect: treat the whole lawn or weed selectively?, J Clin Oncol, 29, 121, 10.1200/JCO.2010.33.3294
Zimm, 1981, Intracerebral metastases in solid-tumor patients: natural history and results of treatment, Cancer, 48, 384, 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8
Coia, 1992, A report of the consensus workshop panel on the treatment of brain metastases, Int J Radiat Oncol Biol Phys, 23, 223, 10.1016/0360-3016(92)90566-Z
Hoskin, 2001, Radiotherapy for brain metastases, Clin Oncol (R Coll Radiol), 13, 91
EuroQol, 1990, EuroQol—a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9
Gerrard, 2003, Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features, Clin Oncol (R Coll Radiol), 15, 422, 10.1016/S0936-6555(03)00148-1
Langley, 2013, Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?, Clin Oncol (R Coll Radiol), 25, e23, 10.1016/j.clon.2012.11.002
Billingham, 2002, Simultaneous analysis of quality of life and survival data, Stat Methods Med Res, 11, 25, 10.1191/0962280202sm269ra
Lutterbach, 2002, Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3, Radiother Oncol, 63, 339, 10.1016/S0167-8140(02)00119-6
Mulvenna, 2010, The management of brain metastases in patients with non-small cell lung cancer—is it time to go back to the drawing board?, Clin Oncol (R Coll Radiol), 22, 365, 10.1016/j.clon.2010.03.011
Nieder, 2000, Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive patitioning analysis (RPA) classes?, Int J Radiat Oncol Biol Phys, 46, 297, 10.1016/S0360-3016(99)00416-2
Taphoorn, 2010, An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients, Eur J Cancer, 46, 1033, 10.1016/j.ejca.2010.01.012
Owen, 2014, The management of brain metastases in non-small cell lung cancer, Front Oncol, 4, 248, 10.3389/fonc.2014.00248